Zhang et al. [29] found that the high expression of IL-22 in the MPE, primary tumour tissues, and serum of patients with non-small cell lung cancer (NSCLC) may be related to the initiation and progression of the disease. This evidence concerns the gene IL22 and non-small cell lung carcinoma.